Method and potentiated composition for treating migraine

Details Method and potentiated composition for treating migraine Method and potentiated composition for treating migraine

A - Human Necessities

61

K

A61K 45/06 (2006.01) A61K 31/13 (2006.01) A61K 31/135 (2006.01) A61K 31/165 (2006.01) A61K 31/275 (2006.01) A61K 31/40 (2006.01) A61K 31/48 (2006.01) A61K 31/485 (2006.01) A61K 31/515 (2006.01) A61K 31/52 (2006.01) A61K 31/60 (2006.01)

Patent

CA 2267893

The migraine-treating effectiveness of an antimigraine drug is significantly enhanced by administering an antimigraine drug together with a nontoxic NMDA receptor blocker and/or a nontoxic substance that blocks at least one major intracellular consequence of NMDA receptor activation.

L'efficacité thérapeutique d'un antimigraineux est considérablement accrue en administrant l'antimigraineux en association avec un inhibiteur non toxique du récepteur du N-méthyl-D-aspartate (NMDA) et/ou une substance non toxique inhibant au moins une conséquence intracellulaire majeure de l'activation du récepteur du NMDA.

Affiliated with

Also associated with

Rating

Method and potentiated composition for treating migraine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method and potentiated composition for treating migraine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and potentiated composition for treating migraine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1458786